Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

Thu, 02nd Sep 2021 09:38

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 10,000 (9,500) PENCE - 'BUY'

----------

JEFFERIES CUTS ANGLO AMERICAN PRICE TARGET TO 4,000 (4,100) PENCE - 'BUY'

----------

JEFFERIES CUTS ANTOFAGASTA PRICE TARGET TO 2,000 (2,100) PENCE - 'BUY'

----------

JEFFERIES CUTS GLENCORE PRICE TARGET TO 460 (480) PENCE - 'BUY'

----------

JEFFERIES CUTS RIO TINTO PRICE TARGET TO 6,500 (7,600) PENCE - 'BUY'

----------

JEFFERIES CUTS BHP GROUP PRICE TARGET TO 2,550 (2,600) PENCE - 'BUY'

----------

BARCLAYS RAISES HIKMA PHARMACEUTICAL TARGET TO 2,900 (2,800) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES MELROSE INDUSTRIES TARGET TO 245 (235) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES ASHTEAD GROUP TARGET TO 6,150 (6,000) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS COCA-COLA HBC TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 2,850 (3,150) PENCE

----------

JPMORGAN CUTS UNILEVER TO 'UNDERWEIGHT' (NEUTRAL) - PRICE TARGET 3,850 (4,200) PENCE

----------

FTSE 250

----------

DEUTSCHE BANK RAISES 888 HOLDINGS PRICE TARGET TO 495 (490) PENCE - 'BUY'

----------

BARCLAYS RAISES HOMESERVE TO 'OVERWEIGHT' (EQUAL WEIGHT) - PRICE TARGET 1,160 (1,200) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

JEFFERIES RAISES SOUTH32 PRICE TARGET TO 175 (170) PENCE - 'HOLD'

----------

RBC RAISES JOHNSON SERVICE PRICE TARGET TO 150 (140) PENCE - 'SECTOR PERFORM'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.